Annual Revenue
$330.53 M
+$222.07 M+204.74%
December 31, 2023
Summary
- As of February 7, 2025, DNLI annual revenue is $330.53 million, with the most recent change of +$222.07 million (+204.74%) on December 31, 2023.
- During the last 3 years, DNLI annual revenue has fallen by -$5.13 million (-1.53%).
- DNLI annual revenue is now -1.53% below its all-time high of $335.66 million, reached on December 31, 2020.
Performance
DNLI Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- DNLI quarterly revenue is not available.
Performance
DNLI Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- DNLI TTM revenue is not available.
Performance
DNLI TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
DNLI Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +204.7% | - | - |
| 3 y3 years | -1.5% | - | - |
| 5 y5 years | +155.9% | - | - |
DNLI Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +579.3% | ||||
| 5 y | 5-year | -1.5% | +1139.0% | ||||
| alltime | all time | -1.5% | +1139.0% |
Denali Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $330.53 M(+204.7%) | - | - |
| Sep 2023 | - | $1.27 M(-99.6%) | $340.81 M(-0.7%) |
| Jun 2023 | - | $294.12 M(+737.0%) | $343.11 M(+238.2%) |
| Mar 2023 | - | $35.14 M(+241.7%) | $101.46 M(-6.5%) |
| Dec 2022 | $108.46 M(+122.9%) | $10.28 M(+188.9%) | $108.46 M(-2.0%) |
| Sep 2022 | - | $3.56 M(-93.2%) | $110.69 M(-1.5%) |
| Jun 2022 | - | $52.48 M(+24.5%) | $112.42 M(+35.6%) |
| Mar 2022 | - | $42.14 M(+236.8%) | $82.88 M(+70.3%) |
| Dec 2021 | $48.66 M(-85.5%) | $12.51 M(+136.8%) | $48.66 M(-86.2%) |
| Sep 2021 | - | $5.29 M(-77.0%) | $352.96 M(-1.2%) |
| Jun 2021 | - | $22.94 M(+189.5%) | $357.07 M(+5.0%) |
| Mar 2021 | - | $7.92 M(-97.5%) | $339.98 M(+1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $335.66 M(+1158.2%) | $316.81 M(+3272.9%) | $335.66 M(+1327.4%) |
| Sep 2020 | - | $9.39 M(+60.6%) | $23.52 M(-15.2%) |
| Jun 2020 | - | $5.85 M(+62.2%) | $27.73 M(+6.3%) |
| Mar 2020 | - | $3.60 M(-22.9%) | $26.08 M(-2.3%) |
| Dec 2019 | $26.68 M(-79.3%) | $4.67 M(-65.7%) | $26.68 M(-81.9%) |
| Sep 2019 | - | $13.60 M(+224.1%) | $147.68 M(+9.2%) |
| Jun 2019 | - | $4.20 M(-0.2%) | $135.27 M(+1.9%) |
| Mar 2019 | - | $4.21 M(-96.7%) | $132.72 M(+2.8%) |
| Dec 2018 | $129.16 M | $125.68 M(>+9900.0%) | $129.16 M(+3607.2%) |
| Sep 2018 | - | $1.20 M(-27.5%) | $3.48 M(+52.2%) |
| Jun 2018 | - | $1.65 M(+157.1%) | $2.29 M(+257.1%) |
| Mar 2018 | - | $641.00 K | $641.00 K |
FAQ
- What is Denali Therapeutics annual revenue?
- What is the all time high annual revenue for Denali Therapeutics?
- What is Denali Therapeutics annual revenue year-on-year change?
- What is the all time high quarterly revenue for Denali Therapeutics?
- What is the all time high TTM revenue for Denali Therapeutics?
What is Denali Therapeutics annual revenue?
The current annual revenue of DNLI is $330.53 M
What is the all time high annual revenue for Denali Therapeutics?
Denali Therapeutics all-time high annual revenue is $335.66 M
What is Denali Therapeutics annual revenue year-on-year change?
Over the past year, DNLI annual revenue has changed by +$222.07 M (+204.74%)
What is the all time high quarterly revenue for Denali Therapeutics?
Denali Therapeutics all-time high quarterly revenue is $316.81 M
What is the all time high TTM revenue for Denali Therapeutics?
Denali Therapeutics all-time high TTM revenue is $357.07 M